Is It Time To Buy MJNA Stocks?

We are seeing full-on capitulation in MJNA stocks as investors run for the hills. The selloff was sparked on Monday after a pair of short-sellers delivered a scathing attack on Aphria Inc (NYSE:APHA). Their game plan has worked so far as Aphria has fallen from $8 before the report was issued to settle at $4.51 yesterday.

APHA Daily Chart

The panic we saw in Aphria has spread throughout the entire cannabis sector and many are now asking if the timing is right to jump in MJNA stocks. We believe the timing is ripe if you look at where some MJNA names were trading just two months ago. Here are a few names worth considering for MJNA investors.

Earlier this summer, Canopy received an investment of CAD $5 billion – or US $4 billion – from Constellation Brands (NYSE:STZ). This started the summer rally for MJNA stocks that lead up to Canada legalizing recreational marijuana use. It was a “buy the rumor, sell the news” event as investors started booking profits. Canopy was trading at just $15 at the start of 2018.

Aurora is now trading at just 25 times earnings and 1.5 times book. This is very cheap for a company in a hot growth sector like cannabis.

In addition to pursuing opportunities in North America, the company has also set its eye on other emerging markets as it looks to diversify its revenue streams. The company has set its sights on the lucrative German cannabis market through its Pedanios subsidiary. The company plans to use Germany as a springboard into other European markets that allow legal use of medical cannabis.

Australia is another country that the company has started cannabis sales, as part of its global expansion drive that has also targeted Brazil and the Cayman Islands. The company has also signed a supply agreement with a South African company, as it also eyes opportunities in Africa.

Cronos Group Inc (NASDAQ:CRON) has held up well in the market selloff after disclosing that Altria Inc (NYSE:MO) is interested in making an investment in the company. Cronos Group operates two wholly-owned Canadian licensed producers: Peace Naturals Project Inc., which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd., which is based in the Okanagan Valley, British Columbia. Cronos Group also has multiple international production and distribution platforms across five continents, which make Cronos an appealing investment for a company like Altria that wants to make a big splash in the space.

CRON Daily Chart

The last MJNA stock we are going to profile today is Tilray Inc (NASDAQ:TLRY). Tilray, in our opinion, is the most speculative as it still has a $9 billion market cap with just $32 million in revenues. The stock is also the most volatile in the MJNA space.

TLRY Daily Chart

Bottom Line

Overall, we believe the long-term story is intact for the MJNA space and the current selloff is a “buy the dip” opportunity. For investors that have a long-term perspective, getting into MJNA stocks is similar to get into tech companies like Amazon.com after the dotcom bubble burst. Investors just need to be patient and scale their purchases because there still might be room for MJNA stocks to fall further. If that happens, it will be a blessing in disguise for those that buy and hold for the next 10 to 15 years. We are at the start of a brand new industry with limitless potential.

We will be updating our subscribers as soon as we know more. For the latest info on MJNA stocks, sign up below!

Disclosure: We have no position in any of the stocks mentioned and have not been compensated for this article.

Enter Symbol For Report

For over five years, we have provided a free service to a countless number of traders featuring only the best in the microcap arena. Insider Financial focuses solely on short-term high probability trade opportunities.

Our alerts consist of Nasdaq, NYSE and high quality OTC companies that are capable of delivering outsized gains to you today, not a year from now. If you have an interest in the lucrative microcap sector, sign up to Insider Financial today!